Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Poletti

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Journal of Affective Disorders|December 31, 2025
Biotypes of deeply phenotyped depressed patients reflect signatures of adverse childhood experience and depressive cognitive biasesFederica Colombo, Federico Calesella, Beatrice Bravi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 25, 2016
Stem Cell Factor (SCF) is a putative biomarker of antidepressant responseFrancesco Benedetti, Sara Poletti, Thomas A Hoogenboezem, et al.
Plos One|November 15, 2017
Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) studyEleonora Maggioni, Benedicto Crespo-Facorro, Igor Nenadic, et al.
Frontiers in Aging Neuroscience|February 22, 2021
Sexual Regional Dimorphism of Post-Adolescent and Middle Age Brain Maturation. A Multi-center 3T MRI StudyGiuseppe Delvecchio, Eleonora Maggioni, Alessandro Pigoni, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 27, 2024
Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistanceFederica Colombo, Federico Calesella, Beatrice Bravi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 25, 2021
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depressionMaria S Simon, Carmen Schiweck, Gara Arteaga-Henríquez, et al.
Human Brain Mapping|January 6, 2025
Predicting Antidepressant Treatment Response From Cortical Structure on MRI: A Mega-Analysis From the ENIGMA-MDD Working GroupMaarten G Poirot, Daphne E Boucherie, Matthan W A Caan, et al.
Journal of Psychopathology and Clinical Science|June 2, 2022
The role of educational attainment and brain morphology in major depressive disorder: Findings from the ENIGMA major depressive disorder consortiumSarah Whittle, Divyangana Rakesh, Lianne Schmaal, et al.
Molecular Psychiatry|March 28, 2026
Cortical morphometry might predict currently prescribed vs. discontinued medications in bipolar disorder, even after controlling for the cumulative dose effects: An ENIGMA mega-analysisLydia Fortea, Miguel Ángel Rivas-Fernández, Aleix Solanes, et al.
Molecular Psychiatry|December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trialsLuca Sforzini, Courtney Worrell, Melisa Kose, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Journal of Affective Disorders|December 31, 2025
Biotypes of deeply phenotyped depressed patients reflect signatures of adverse childhood experience and depressive cognitive biasesFederica Colombo, Federico Calesella, Beatrice Bravi, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|April 25, 2016
Stem Cell Factor (SCF) is a putative biomarker of antidepressant responseFrancesco Benedetti, Sara Poletti, Thomas A Hoogenboezem, et al.
Plos One|November 15, 2017
Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) studyEleonora Maggioni, Benedicto Crespo-Facorro, Igor Nenadic, et al.
Frontiers in Aging Neuroscience|February 22, 2021
Sexual Regional Dimorphism of Post-Adolescent and Middle Age Brain Maturation. A Multi-center 3T MRI StudyGiuseppe Delvecchio, Eleonora Maggioni, Alessandro Pigoni, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 27, 2024
Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistanceFederica Colombo, Federico Calesella, Beatrice Bravi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 25, 2021
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depressionMaria S Simon, Carmen Schiweck, Gara Arteaga-Henríquez, et al.
Human Brain Mapping|January 6, 2025
Predicting Antidepressant Treatment Response From Cortical Structure on MRI: A Mega-Analysis From the ENIGMA-MDD Working GroupMaarten G Poirot, Daphne E Boucherie, Matthan W A Caan, et al.
Journal of Psychopathology and Clinical Science|June 2, 2022
The role of educational attainment and brain morphology in major depressive disorder: Findings from the ENIGMA major depressive disorder consortiumSarah Whittle, Divyangana Rakesh, Lianne Schmaal, et al.
Molecular Psychiatry|March 28, 2026
Cortical morphometry might predict currently prescribed vs. discontinued medications in bipolar disorder, even after controlling for the cumulative dose effects: An ENIGMA mega-analysisLydia Fortea, Miguel Ángel Rivas-Fernández, Aleix Solanes, et al.
Molecular Psychiatry|December 15, 2021
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trialsLuca Sforzini, Courtney Worrell, Melisa Kose, et al.
Pageof 15